Home - Products - Others - Other Targets - 6-Methoxyeriodictyol-7-O-β-D-glucopyranoside

6-Methoxyeriodictyol-7-O-β-D-glucopyranoside

CAS No. 1627598-00-8

6-Methoxyeriodictyol-7-O-β-D-glucopyranoside( ——— )

Catalog No. M38265 CAS No. 1627598-00-8

5,7,3',4'-Tetrahydroxy-6-methoxyflavanone-7-glucoside (compound4) can be isolated from the Salvia plebeia R.Br.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-Methoxyeriodictyol-7-O-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    5,7,3',4'-Tetrahydroxy-6-methoxyflavanone-7-glucoside (compound4) can be isolated from the Salvia plebeia R.Br.
  • Description
    5,7,3',4'-Tetrahydroxy-6-methoxyflavanone-7-glucoside (compound4) can be isolated from the Salvia plebeia R.Br.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1627598-00-8
  • Formula Weight
    480.42
  • Molecular Formula
    C22H24O12
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Da-Bing Ren, et al. Separation of nine compounds from Salvia plebeia R.Br. using two-step high-speed counter-current chromatography with different elution modes. J. Sep. Sci. 2014, 37.
molnova catalog
related products
  • A-G-D-V

    A-G-D-V

  • fulvotomentoside A

    Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.

  • Cyclic MKEY

    MKEY, a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, has been shown to protect against atherosclerosis and aortic aneurysm formation by mediating inflammation, but whether it modulates neuroinflammation and brain injury has not been studied.